Clinical Trial Update: A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for CXD101 plus nivolumab in metastatic microsatellite-stable colorectal cancer (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasms Malignant

Drugs mentioned

• CXD101
• nivolumab (nivolumab)

Snippet

Sponsor: Celleron Therapeutics Ltd. | Conditions: Colorectal Neoplasms Malignant | Phase 1, Phase 2 | Status: UNKNOWN